Japan Statin Treatment Against Recurrent Stroke (J-STARS)

Completed

Phase 3 Results

Summary of Purpose

Although hyperlipidemia is not always the risk factor of stroke, inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) reductase can decrease the incidence of stroke in the patient with ischemic heart disease. The neuroprotective mechanism beyond cholesterol lowering should be expected to attenuate inflammation and atherosclerosis. The present study hypothesizes if pravastatin prevents recurrent stroke in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 June 2017.

1 Mar 2004 13 Sep 2005 1 Jul 2014 Unavailable 1 Jun 2017 6 Jul 2016
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available